Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") announced that it has discontinued development of fezagepras.
The decision to discontinue the development of fezagepras is...
Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company"), announced that the first subject has been dosed in the Company's Phase 1a single ascending dose...